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Abstract
Background and Objectives: Asthma and depression are common health problems in primary care. Evidence of a
relationship between asthma and depression is conflicting. Objectives: to determine 1. The incidence rate and incidence
rate ratio of depression in primary care patients with asthma compared to those without asthma, and 2. The standardized
mortality ratio of depressed compared to non-depressed patients with asthma.
Methods: A historical cohort and nested case control study using data derived from the United Kingdom General Practice
Research Database. Participants: 11,275 incident cases of asthma recorded between 1/1/95 and 31/12/96 age, sex and
practice matched with non-cases from the database (ratio 1:1) and followed up through the database for 10 years. 1,660
cases were matched by date of asthma diagnosis with 1,660 controls. Main outcome measures: number of cases diagnosed
with depression, the number of deaths over the study period.
Results: The rate of depression in patients with asthma was 22.4/1,000 person years and without asthma 13.8 /1,000 person
years. The incident rate ratio (adjusted for age, sex, practice, diabetes, cardiovascular disease, cerebrovascular disease,
smoking) was 1.59 (95% CI 1.48–1.71). The increased rate of depression was not associated with asthma severity or oral
corticosteroid use. It was associated with the number of consultations (odds ratio per visit 1.09; 95% CI 1.07–1.11). The age
and sex adjusted standardized mortality ratio for depressed patients with asthma was 1.87 (95% CI: 1.54–2.27).
Conclusions: Asthma is associated with depression. This was not related to asthma severity or oral corticosteroid use but
was related to service use. This suggests that a diagnosis of depression is related to health seeking behavior in patients with
asthma. There is an increased mortality rate in depressed patients with asthma. The cause of this needs further exploration.
Consideration should be given to case-finding for depression in this population.
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Introduction
After hypertension asthma is the most common chronic illness
in primary care in the United Kingdom with a prevalence 6% [1].
Depression also has a high prevalence in primary care of between
5 and 10% [2]. Chronic physical health problems are reported to
be associated with increased rates of depression [3].
Whether there is an association between asthma and depression
is unclear. In secondary care populations up to 50% of patients
with asthma have been reported to have clinically significant
depressive symptoms and over a third of asthmatic outpatients
have been found to have a major depressive episode [4,5,6,7,8,9].
The World Mental Health Survey found an age and sex adjusted
odds ratio of 1.6 for depression in people with asthma compared to
people without asthma [10,11]. However other researchers have
failed to find an association [12,13,14], and there has been little
research in primary care populations where the majority of people
with these conditions are treated. Most studies to date have been
cross-sectional in design and so the ability to explore potential
associations has been limited. Longitudinal studies are needed to
explore potential associations further.
The aims of this study were to determine the incidence of
depression in primary care patients with asthma and the incidence
rate ratio (IRR) of depression in this population compared to the
general primary care population without asthma. We also wanted
to explore potential mediators of this relationship and examine all
cause mortality in patients with asthma and depression compared
with non depressed patients with asthma.
We hypothesised that:
1. Primary care patients with asthma would have an increased
incidence of depression compared with primary care patients
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other common chronic medical conditions (coronary heart
disease, diabetes and cardiovascular accidents) and oral
corticosteroid medication use and smoking status.
2. Primary care patients with asthma and depression would have
a higher age and sex standardized mortality rate compared
with primary care patients with asthma but no depression.
Methods
Study design
This was a historical cohort study with a nested case-control
study using data derived from the General Practice Research
Database.
General Practice Research Database
The UK General Practice Research Database (GPRD) is the
world’s largest database of anonymous longitudinal medical data
from primary care (www.gprd.com). The database consists of the
medical records of approximately 13 million primary care patients
with 46 million years of validated data. In 1996, 480 practices
across the UK contributed to the GPRD. Recorded data include
diagnoses, clinical events, specialist referrals, prescription details,
hospital admissions and outcomes. Each patient has a unique
identifier which allows data held in 4 separate data-sets to be
linked. The GPRD uses Oxford Medical Information System
(OXMIS) codes and Read codes to store diagnostic information
[15]. These are cross- referenced to the International Classification
of Diseases (ICD9 and ICD10) by the UK National Health Service
Information Authority.
The database is owned and managed by the Medicines and
Healthcare Products Regulatory Agency (MHRA) in the UK. The
quality of the data are regularly audited by the Office for National
Statistics and only practices that are ‘up-to-research standard’
(UTS) are eligible to participate. The GPRD has been validated
for use in respiratory epidemiology [16], and the results from the
database for asthma are consistent with published studies on the
epidemiology of asthma [17]. Comparisons of age and sex
distributions are similar to those found in the National Population
Census and the geographical distribution of practices participating
in the GPRD is representative of the UK population [18].
Historical cohort study
All patients aged 16 years or over with an incident diagnosis of
asthma in their primary care record given between 1
st January
1995 and 31
st December 1996 and who had at least 24 months of
UTS data before the start of the study window were identified
from the GPRD, and followed up until 31 December 2006. A
medical diagnosis of asthma was defined by a Read/ OXMIS
code for asthma (codes available from authors). Read/OXMIS
codes for asthma can de cross-referenced to ICD-10 asthma codes.
All cases with a recorded medical diagnosis of depression (as
defined by Read/OXMIS codes) or depressive symptoms before
the 1
st January 1995 were excluded from the cohort. Additionally,
cases with a recorded diagnosis of schizophrenia or bipolar
affective disorder (as defined by Read/OXMIS codes) over the
study period were also excluded (Read/OXMIS codes used
available from authors).
Patients were age (62 years), sex and practice matched (ratio
1:1) with patients who had not received a diagnosis of asthma over
the same study period taken from the same GPRD base
population of registered patients. GP practice was used as a proxy
to control for socio-economic status as this was not directly
available from data in the GPRD. GP practice has been found to
correlate with socioeconomic status in the United Kingdom with
practice postcode based Index of Multiple Deprivation (IMD)
scores being correlated with population weighted IMD scores [19].
All patients had at least 24 months of UTS data prior to the index
date of the case.
Patients were censored if they received a diagnosis of depression
during the study period to prevent over-estimating any association
due to recurrent depressive disorders in those that had already
been diagnosed with depression during the study period.
Nested case control study
Cases were defined as patients from the cohort study with a
diagnosis of asthma and depression (as defined by Read/OXMIS
codes) during the study period. Controls were defined as patients
from the cohort study with a medical diagnosis of asthma but
without a diagnosis of depression (as defined by Read/OXMIS
codes) during the study period. Cases were matched to controls
(ratio 1:1) according to the date of asthma diagnosis (61 month).
The same inclusion and exclusion criteria were applied to both
cases and controls and were the same as those for the cohort study.
Measures
The exposure of interest was a GP recorded diagnosis of asthma.
The outcome of interest was a GP recorded diagnosis of depression.
Data on smoking status (defined as ever having smoked), co-
morbidity with other common chronic illnesses (diabetes mellitus,
cerebrovascular disease, coronary heart disease and congestive
heart failure), anxiety disorders, asthma medications use (b-agonist
use, inhaled corticosteroids and oral corticosteroids), and the
number of GP consultations were obtained from the electronic
medical records. The co-morbid illnesses were defined by a Read/
OXMIS code for any of these diagnoses prior to the onset of
depression in the cases, and prior to the same date in the matched
control.
As has been validated in another study, asthma medications
patients had received in the year before being given a diagnosis of
depression were used as a proxy for asthma severity as follows: 1.
Un-medicated asthma (no prescriptions) 2. Asthma medicated with
at least one prescription of a short acting b-agonist. 3. Asthma
medicated with at least one prescription for an inhaled corticoste-
roid with or without a long acting b-agonist. 4. asthma medicated
with an oral corticosteroid [20]. The number of GP consultations in
the year before the onset of depression for the cases and the number
in the year before the same date for each matched control were
recorded. These were further categorised into low use (,5
consultations), medium use (5–10 consultations), high use (10–19
consultations), and very high use ($20 consultations).
Statistical analysis
All data were analysed using STATA version 9 (STATA Corp,
Texas). The incidence rate and summary rates of depression
stratified by age and sex were calculated. Rate ratios and 95%
confidence intervals were calculated for the exposed and
unexposed groups. Multivariate survival analyses were used to
control for potential confounders using the ‘streg’ function in
STATA. The ‘cluster’ option in STATA was used to allow for the
effect of correlations within matched groups on estimates of
standard errors and significance levels. Conditional logistic
regression analysis was used to explore associations between cases
(asthma and depression), controls (asthma but no depression) and
to take into account the effect of potential confounders.
Standardised mortality ratios (SMR) controlling for age and sex
were calculated indirectly.
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misclassification of depression and asthma. For depression, the
results were re-analysed excluding patients who had also received
a Read/OXMIS diagnosis of anxiety or an anxiety disorder, and
also by defining depression as a Read/OXMIS code for
depression and being prescribed an antidepressant medication.
The analyses were also repeated excluding patients who had also
received a diagnosis of chronic obstructive pulmonary disease
(COPD), and also restricting the inclusion criteria to those aged
less than 40 years, as a diagnosis of COPD is unlikely before this
age.
Ethical Approval. This is an analysis of an anonymised data
set. Ethical approval was covered under the terms and conditions
of use of the General Practice Research Database via the Medical
Research Council.
Results
Incidence of depression in patients with asthma
11,275 incident cases of asthma were identified between 1
st
January 1995 and 31
st December 1996 from 219 practices. It was
possible to age- sex- and practice-match all cases (ratio 1:1) giving
a total case-control cohort population of 22,550. Fifty seven
percent were female. The average age of men was 50 years
(s.d.18.9), women 48 years (standard deviation (s.d.) 19) (p,0.001).
Patients with asthma were followed up in the GRPD for 78,096
person years and patients without asthma for 98,229 person years.
In the population with asthma 1752 were diagnosed with
depression over the study period and in the population without
asthma, 1353 were diagnosed with depression over the same
period.
The incident rate for depression in patients with asthma was
22.4 per 1000 person years. The incidence rate for depression in
age-, sex- and practice matched patients without asthma was 13.8
per 1000 person years, giving an incident rate ratio (IRR) of 1.63
(95% CI: 1.52–1.75). There was no statistically significant
difference between the incidence rate ratios for depression in the
asthmatic population versus non-asthmatic population by sex (IRR
men=1.64 ;95% CI: 1.44–1.87; IRR women 1.63; 95% CI: 1.49–
1.77) (Mantel-Haenszel test for homogeneity x
2=0.01; d.f. 1;
p=0.912) or by age (Mantel-Haenszel test for homogeneity
x
2=8.54; d.f. 6; p=0.20). After adjusting, diabetes, cardiovascular
disease, cerebrovascular disease, and smoking status the age sex
and practice matched IRR was 1.59 (95%CI: 1.48–1.71).
Sensitivity analyses did not statistically significantly change the
model (sensitivity analyses results available on request from the
authors).
Nested case-control study
Of the 1752 patients with asthma who became depressed, it was
possible to match 1660 controls by date of asthma diagnosis (61
month) giving a total population for the case-control study of 3320
patients. Data on service use were available for 1648 (99%)
controls and 1355 (82%) cases. Fifty-three per cent of the controls
were women and 70% of the cases. The average age of controls
was 49.6 years ( s.d.18.5) and the average age of the cases was 46.1
years (s.d. 18.7; p,0.001). The crude odds ratio for depression in
women with asthma compared to men with asthma was 2.09
(95%CI:1.93–2.24). There was a small decreasing trend in the
effect of age on depression (crude OR for each additional year
0.99; 95%CI: 0.987–0.994).
The mean number of GP consultations in the year prior to
diagnosis of depression in the cases was 8.3 (s.d.7.1) and in the
same year in the controls was 5.3 (s.d.5.67) (Mann-Whitney test
p,0.001). The age and sex adjusted OR for the association
between each GP visit and diagnosis of depression was 1.1 (95%
CI 1.07–1.10). The average number of consultations across cases
and controls was 6.7 (s.d.6.5). The association between the number
of GP visits, severity of asthma and diagnosis of depression is
shown in Table 1. The Spearman’s correlation coefficient (r) for
asthma severity and number of GP visits was 0.3.
There were statistically significantly more cases than controls
being treated with any anti-asthmatic medication (controls 48.2%,
cases 51.8%; p=0.01) and with oral corticosteroids in the year
before inclusion in the study (controls 42.6%, cases 57.4%;
p,0.001). Cases and controls were as likely to have b2 agonists as
the highest level of treatment (controls 47.6%, cases 52,4%;
p=0.268), and inhaled corticosteroids (controls 51.2%, cases
48.8%; p=0.345). However being treated with an oral corticoste-
roid was no longer statistically significant after adjusting for the
number of GP consultations (See Table 2).
The age and sex standardised SMR for primary care patients
with asthma compared to the general primary care population was
2.86 (95%CI: 2.64–3.10). The age and sex standardised mortality
ratio for primary care patients with asthma and depression
compared with non-depressed patients with asthma was 1.87
(95%CI: 1.54–2.27).This did not change statistically significantly
with asthma severity.
Discussion
We have found a statistically significant association between a
diagnosis of asthma and the incidence of depression in primary
care patients, and a higher mortality rate in patients with asthma
and depression compared to patients with asthma only. This
finding is particularly important as asthma is one of the
commonest chronic conditions treated in primary care and an
association between asthma and depression has potentially
important implications for public health. In the UK, case-finding
for depression has been instituted for primary care patients with
diabetes and coronary heart disease [21], but not for asthma.
Asthma is more common than coronary heart disease [22,23] and
Table 1. Association between predictor variables and
depression in primary care patients with asthma.
OR
1 p-value 95% Confidence Interval
Number of GP visits*:
0–4 visits 1
5–9 visits 1.85 ,0.001 1.53–2.25
10–19 visits 3.21 ,0.001 2.53–4.08
$20 visits 4.51 ,0.001 3.20–6.36
Per visit 1.09 ,0.001 1.07–1.11
Asthma severity**:
No medication 1
b2-Agonists 1.26 0.083 0.97–1.64
Inhaled corticosteroids 1.16 0.217 0.92–1.47
Oral corticosteroids 1.76 ,0.001 1.33–2.31
1Adjusted for age and sex.
*In year prior to inclusion into the case-control study (year prior to diagnosis of
depression in the cases); [cases n=1355, controls n=1647].
**Highest ‘level’ of treatment in year prior to inclusion into the case-control
study (year prior to diagnosis of depression in the cases) [cases n=1660,
controls n=1660].
doi:10.1371/journal.pone.0020750.t001
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depression and asthma may be as strong as that between
depression in coronary heart disease and diabetes. Case-finding
for depression in this population should therefore be considered.
An increased mortality rate in patients with co-morbid asthma
and depression has also been reported for asthma patients treated
in tertiary care [4]. It has been hypothesised that concurrent
depression leads to poor adherence with asthma treatments and
hence to poorer outcomes [25]. Eisner et al reported that
depressive symptoms were also associated with an increased risk
of being hospitalised for asthma [26]. Due to limitations of the
dataset we were unable to determine the cause of death in our
study and further research is needed to explore the reasons for the
increased mortality in this population.
Our results suggest that asthma predisposes to developing
depression. However, this did not appear to be contingent on
asthma severity. Evidence for an association between asthma
severity and depression is contradictory. Eisner et al found that in a
prospective cohort of patients hospitalised for asthma, depressive
symptoms did increase with asthma severity [26], though
Chapman et al reported that patients with mild asthma reported
depression as frequently as those with severe asthma [27]. Our
results are in line with those of Chapman et al. The reason for this
counter-intuitive result is unclear. One explanation is that
objective measures of asthma severity (such as peak expiratory
flow rate) do not necessarily reflect subjective experience [14].
Oral corticosteroid use is unlikely to be the cause of the
increased rate of depression in patients with asthma. We failed to
find an association between inhaled or oral corticosteroid use and
depression after adjusting for number of primary care consulta-
tions. The correlation between asthma severity and number of
primary care consultations was low. Frequent attendance in
primary care has been associated with receiving a diagnosis of
depression and so patients with asthma who are frequent attendees
may have a higher likelihood of being diagnosed with depression.
An increased frequency of attendance may increase the opportu-
nity for primary care doctors to detect depression or may reflect an
underlying depression leading to an increased number of
consultations. Primary care physicians should therefore consider
depression in frequent attendees who have asthma.
Limitations
The data in the GPRD are essentially computerised general
practice records, completed as part of routine clinical care. They
should therefore reflect clinical practice. However there are
limitations. Diagnoses were those given by GPs and no
standardised instruments were used to confirm this diagnosis.
There have been no studies we are aware of that have examined
the validity of diagnoses for depression in the GPRD, though a
study of psychosis diagnoses using this database found high
predictive values [28]. We conducted sensitivity analyses to
explore the possible effects of misclassification of depression and
these were minimal. Loss to follow-up from the cohort should also
be minimal as registration with primary care and exits from the
database are carefully recorded. We were unable to assess the
severity of asthma directly, and had to use a medication based
proxy, though this has been used successfully in other studies [20].
However we were unable to measure adherence to medications.
Poor adherence may result in fewer visits to a GP because patients
would not have to attend to for further prescriptions, or it could
result in poorer asthma control which may in turn result in more
visits. Poor compliance may therefore be a residual confounder.
The case-control study may be subject to residual confounding
for example from socioeconomic status. The relationship between
socioeconomic status and asthma is unclear with conflicting
evidence of an association [29]. Likewise, though there appears to
be a relationship between the prognosis of depression and
socioeconomic status, the association between the incidence of
depression and socioeconomic status is less clear [30]. Nevertheless
we considered socioeconomic status to be a potential confounder.
We were unable to assess socioeconomic status directly and had to
use GP practice as a proxy. GP practice has been found to
correlate with socioeconomic status at the individual level, though
it is only an approximation of the area-based deprivation of the
practice population as a whole [19]. This may lead the strength of
the association between asthma and depression to be overestimat-
ed. It is unlikely that frequency of attendance at GP practices is
confounded by socioeconomic status. Higher rates of consultation
have not been found to be related to socioeconomic status, but
rather the number of underlying chronic medical conditions
(which is associated to socioeconomic status) [31]. We controlled
Table 2. Adjusted Odds ratios (OR) for depression in primary care patients with asthma.
Adjusted OR p-value 95% confidence interval
GP visits in year prior to study inclusion (cases n=1355, controls n=1647):
,5 visits 1
5–9 visits 1.91* ,0.001 1.57–2.31
10–19 visits 3.35* ,0.001 2.62–4.28
$20 visits 4.70* ,0.001 3.32–6.65
Per visit 1.09* ,0.001 1.07–1.11
Asthma severity (cases n=1660, controls n=1660):
No medication 1
b2-Agonists 0.83** 0.192 0.64–1.09
Inhaled corticosteroids 0.81** 0.056 0.66–1.01
Oral corticosteroids 0.88** 0.372 0.67–1.16
SMR
1 1.87 1.54–2.27
*Adjusted for age, sex and severity (type of treatment in the year prior to inclusion in the study).
**Adjusted for age, sex and number of GP visits in year prior to inclusion in study.
1Age and Sex Standardised Mortality Ratio for primary care patients with asthma and depression versus those with asthma but no depression.
doi:10.1371/journal.pone.0020750.t002
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practice and though there may still be residual confounding from
medical conditions we did not control for this is likely small.
In conclusion, there is a higher incidence of depression recorded
by GPs in patients with asthma, and co-morbid asthma and
depression increases mortality. A diagnosis of depression does not
seem to be related to asthma severity, but is related to the
frequency of GP consultation. Depression screening should be
considered in primary care patients with asthma.
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